InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
sawduster Free
11/17/17 8:28 PM
profile icon
Longer Than Most Free
11/15/17 12:35 PM
profile icon
stocktrademan Free
06/23/17 11:51 AM
profile icon
JAG69 Free
06/23/17 11:36 AM
profile icon
stocktrademan Free
06/05/17 11:10 AM

OpGen, Inc. Warrants (OPGNW) RSS Feed

Followers
2
Posters
4
Posts (Today)
0
Posts (Total)
5
Created
06/05/17
Type
Free
Moderators
OpGen, Inc. 708 Quince Orchard Road Suite 205 Gaithersburg, MD 20878 United States 301-869-9683 http://www.opgen.com OpGen, Inc., a precision medicine company, engages in developing molecular information products and services to combat infectious diseases in the healthcare industry worldwide. The company utilizes molecular diagnostics and bioinformatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The companys products include QuickFISH and PNA FISH products, which are FDA-cleared and CE-marked in vitro diagnostic tests designed to identify antimicrobial resistant pathogens, as well as XpressFISH diagnostic test products for the identification of various infectious pathogens. It also provides Acuitas MDRO Gene Test, Acuitas CR Elite Test, and Acuitas Resistome Test that are CLIA lab-based tests, which provide a profile of MDRO resistant genes for surveillance and response to outbreaks. In addition, the company offers Acuitas Lighthouse bioinformatics systems, which are cloud-based HIPAA compliant bioinformatics offerings that combine clinical lab test results with patient and hospital information, and provide analytics to enable manage MDROs in the hospital and patient care environment. Further, it engages in the development of Acuitas Rapid Test designed to detect the primary resistome profiles of gram negative organisms. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
OPGNW Latest News
  • No Recent News Available for this company!
New Post